Skip to main content

Advertisement

SpringerLink
Log in

Unresolved Inflammation and Cancer: Loss of Natural Immune Surveillance as the Correct ‘Target’ for Therapy! Seeing the ‘Elephant’ in the Light of Logic

  • Commentary
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Selected References by the Author

  1. Khatami, M. (2011). Unresolved inflammation: ‘Immune tsunami’ or erosion of integrity in immune-privileged and immune-responsive tissues and acute and chronic inflammatory diseases or cancer. Expert Opinion on Biological Therapy, 11, 1419–1432.

    Article  PubMed  CAS  Google Scholar 

  2. Khatami, M. (2009). Inflammation, aging and cancer: Tumoricidal vs tumorigenesis of immunity: A common denominator mapping chronic diseases. Cell Biochemistry and Biophysics, 55, 55–79.

    Article  PubMed  CAS  Google Scholar 

  3. Khatami, M. (2008). “Yin and Yang” in inflammation: Duality in innate immune cell function and tumorigenesis. Expert Opinion on Biological Therapy, 8, 1461–1472.

    Article  PubMed  CAS  Google Scholar 

  4. Khatami, M. (2011). Inflammation, aging and cancer: Friend or foe? In M. Khatami (Ed.), Inflammation, aging and cancer. Croatia: InTech Publishing (in press).

  5. Khatami, M., Donnelly, J. J., Haldar, J. P., & Rockey, J. H. (1989). Massive follicular lymphoid hyperplasia in experimental chronic recurrent allergic conjunctivitis. Archives of Ophthalmology, 107, 433–438.

    Article  PubMed  CAS  Google Scholar 

  6. Khatami, M. (2005). Developmental phases of inflammation-induced massive lymphoid hyperplasia and extensive changes in epithelium in an experimental model of allergy. Implications for a direct link between inflammation and carcinogenesis. American Journal of Therapeutics, 12, 117–128.

    Article  PubMed  Google Scholar 

  7. Khatami, M. (2005). Cyclooxygenase inhibitor Ketorolac or mast cell stabilizers: Immunological challenges in cancer therapy. Letters to the Editor. Clinical Cancer Research, 11, 1350–1352.

    Google Scholar 

  8. Khatami, M. (2007). Standardizing cancer biomarkers criteria: Data elements as foundation of a database. M-CSF (Model Marker) for early detection of cancer. Cell Biochemistry and Biophysics, 47, 187–198.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section on Immunology, Inflammation, Aging and Cancer, Cell Biochemistry and Biophysics (CBB), Bethesda, MD, USA

    Mahin Khatami

Authors
  1. Mahin Khatami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahin Khatami.

Additional information

Associate Editor: Mahin Khatami.

Mahin Khatami retired from the National Cancer Institute (NCI), the National Institutes of Health (NIH), Bethesda, MD, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khatami, M. Unresolved Inflammation and Cancer: Loss of Natural Immune Surveillance as the Correct ‘Target’ for Therapy! Seeing the ‘Elephant’ in the Light of Logic. Cell Biochem Biophys 62, 501–509 (2012). https://doi.org/10.1007/s12013-011-9319-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-011-9319-9

Keywords

Search

Navigation